Related Experiment Video
Updated: Mar 22, 2026

07:47
Non-Invasive Electrical Brain Stimulation Montages for Modulation of Human Motor Function
Published on: February 4, 2016
13.7K
Non-Invasive Brain Stimulation in Conversion (Functional) Weakness and Paralysis: A Systematic Review and Future
Carlos Schönfeldt-Lecuona1, Jean-Pascal Lefaucheur2, Peter Lepping3
1Department of Psychiatry and Psychotherapy III, University of Ulm Ulm, Germany.
Frontiers in Neuroscience
|April 12, 2016
Summary
Non-invasive brain stimulation (NIBS) shows promise for functional weakness (FW) treatment, with repetitive transcranial magnetic stimulation (rTMS) demonstrating satisfactory short-term symptom improvement in most patients. However, the limited and low-quality studies necessitate cautious interpretation and further research.
Area of Science:
- Neurology
- Neuroscience
- Psychiatry
Background:
- Functional weakness (FW) is a debilitating condition often requiring multidisciplinary treatment.
- Non-invasive brain stimulation (NIBS) methods like electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) have been explored for FW.
- Existing treatments typically combine behavioral approaches with motor learning programs.
Purpose of the Study:
- To systematically review the literature on NIBS methods (ECT, TMS, tDCS) for treating FW.
- To retrospectively assess symptom changes using Clinical Global Impression scale-Improvement (CGI-I) scores.
- To elucidate the potential role of NIBS in FW and recommend future study designs.
Main Methods:
- Systematic literature review of PubMed and Web of Science for studies using NIBS (ECT, TMS, tDCS) in FW patients.
- Retrospective determination of nominal CGI-I scores from case narratives to quantify symptom improvement.
- Analysis of identified studies focusing on patient numbers, treatment methods, and reported outcomes.
Main Results:
- Two case reports on ECT and five studies on TMS (86 patients) were identified; no tDCS studies were found.
- Repetitive TMS (rTMS) showed satisfactory short-term improvement in 75/86 patients, with 72% achieving "very much improved" (CGI-I=1).
- No severe adverse effects were reported for rTMS; ECT showed short-term response but symptom deterioration at follow-up.
Conclusions:
- NIBS, particularly rTMS, demonstrates potential for short-term improvement in FW symptoms, though long-term efficacy is unclear.
- The limited number and poor quality of existing studies warrant caution when assuming a beneficial effect of NIBS in FW.
- Further high-quality research with robust study designs is recommended to establish the efficacy of NIBS for functional weakness.

